Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab with surgery for moderate to severe hidradenitis suppurativa
2015-005161-23Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- May 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hidradenitis suppurativa (HS) comparing Adalimumab + surgery with Placebo + surgery (2 arms). Primary endpoint: HiSCR response. Started May 2016; status: completed.
02
Drugs
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2015-005161-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005161-23.